Med Pharma Retatrutide 32mg Pen
RETATRUTIDE (RTR-32) – 32 mg Synthetic Peptide | Triple Receptor Agonist Reta Trutide (Retatrutide) is a clinical-stage investigational peptide being studied for its activity on three metabolic hormone receptors: GLP-1, GIP, and glucagon receptors. The product is presented as a 32 mg / 3.0 ml prefilled injection pen and is intended for research and investigational use only. Product Details: Active ingredient: Retatrutide (RTR-32) Strength: 32 mg / 3.0 ml Form: Prefilled injection pen Classification: Investigational synthetic peptide Triple receptor agonist: GLP-1 / GIP / Glucagon
Variants (1)
- Default Title — 19000.00 EGP — In stock
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
72%